BioCentury | Apr 15, 2021
Deals

Genechem’s bispecifics deal with I-Mab marks debut for a global strategy 20 years in the making

...and a member of the board of Biogen Inc....
BioCentury | Apr 15, 2021
Regulation

April 14 Quick Takes: GSK stops two trials of ICOS agonist; plus Trodelvy, Amylyx, Junshi, Jazz, MitoChem

...1 ligand 1 BC Staff Trodelvy, sacituzumab govitecan (hRS7-SN-38, IMMU-132) Jazz Pharmaceuticals plc Amylyx Pharmaceuticals Inc. Gilead Sciences Inc. Sage Therapeutics Inc. Biogen Inc. Shanghai...
BioCentury | Apr 14, 2021
Management Tracks

CEO succession at Amarin; plus Lilly, IGM, Jounce and more

...Rivassou joined Kurma Partners as a partner. Rivassou previously served as investment director at ISAI. BC Staff Biogen Inc. Amarin...
BioCentury | Apr 12, 2021
Politics, Policy & Law

Cavazzoni brings competence, continuity as CDER director

...staff.  Some of her first high-profile decisions will involve CDER’s regulatory decision on aducanumab from Biogen Inc....
...adopt lessons learned from the experience. Steve Usdin U.S. Food and Drug Administration (FDA) Pfizer Inc. Eli Lilly and Co. Sanofi Biogen Inc. Patrizia...
BioCentury | Apr 9, 2021
Deals

April 8 Quick Takes: Hologic buying Mobidiag for nearly $800M; plus Biogen-Bio-Thera, Dicerna royalty sale, a SPAC for LumiraDx, Cidara-Janssen and Chi-Med’s $100M

...respiratory infections, antimicrobial resistance management, and healthcare-associated infections. It generated about $42 million in 2020 revenue.Biogen...
...to funds affiliated with Baring Private Equity Asia at $30.50 per ADS. BC Staff Hologic Inc. Mobidiag Ltd. Dicerna Pharmaceuticals Inc. Biogen Inc. Bio-Thera...
BioCentury | Apr 1, 2021
Management Tracks

Remembering Gilead’s John Martin, whose therapies saved ‘millions’

...our space,” said Stelios Papadopoulos, chairman of Biogen Inc....
BioCentury | Mar 31, 2021
Finance

March 31 Quick Takes: Muted reception for Achilles in market debut; plus BridgeBio-Helsinn, Scribe, Outpace, OnQuality, AffaMed, Treos

...Berkeley professor Jennifer Doudna, the company emerged from stealth in October with a deal with Biogen Inc....
BioCentury | Mar 26, 2021
Product Development

Three’s a crowd in SMA sales: Data Byte

...appreciable Evrysdi sales.Antisense oligo Spinraza nusinersen from Biogen Inc....
BioCentury | Mar 26, 2021
Finance

As valuation swells above $380M, Syncona-backed Gyroscope draws $148M series C, mulls listing

...which went public on NASDAQ in 2017; Biogen Inc....
BioCentury | Mar 22, 2021
Product Development

Genomics plc puts polygenic risk scores to the test with NHS pilot

...$58 million in series A and series B funding, and formed target discovery partnerships with Biogen Inc....
Items per page:
1 - 10 of 5047
BioCentury | Apr 15, 2021
Deals

Genechem’s bispecifics deal with I-Mab marks debut for a global strategy 20 years in the making

...and a member of the board of Biogen Inc....
BioCentury | Apr 15, 2021
Regulation

April 14 Quick Takes: GSK stops two trials of ICOS agonist; plus Trodelvy, Amylyx, Junshi, Jazz, MitoChem

...1 ligand 1 BC Staff Trodelvy, sacituzumab govitecan (hRS7-SN-38, IMMU-132) Jazz Pharmaceuticals plc Amylyx Pharmaceuticals Inc. Gilead Sciences Inc. Sage Therapeutics Inc. Biogen Inc. Shanghai...
BioCentury | Apr 14, 2021
Management Tracks

CEO succession at Amarin; plus Lilly, IGM, Jounce and more

...Rivassou joined Kurma Partners as a partner. Rivassou previously served as investment director at ISAI. BC Staff Biogen Inc. Amarin...
BioCentury | Apr 12, 2021
Politics, Policy & Law

Cavazzoni brings competence, continuity as CDER director

...staff.  Some of her first high-profile decisions will involve CDER’s regulatory decision on aducanumab from Biogen Inc....
...adopt lessons learned from the experience. Steve Usdin U.S. Food and Drug Administration (FDA) Pfizer Inc. Eli Lilly and Co. Sanofi Biogen Inc. Patrizia...
BioCentury | Apr 9, 2021
Deals

April 8 Quick Takes: Hologic buying Mobidiag for nearly $800M; plus Biogen-Bio-Thera, Dicerna royalty sale, a SPAC for LumiraDx, Cidara-Janssen and Chi-Med’s $100M

...respiratory infections, antimicrobial resistance management, and healthcare-associated infections. It generated about $42 million in 2020 revenue.Biogen...
...to funds affiliated with Baring Private Equity Asia at $30.50 per ADS. BC Staff Hologic Inc. Mobidiag Ltd. Dicerna Pharmaceuticals Inc. Biogen Inc. Bio-Thera...
BioCentury | Apr 1, 2021
Management Tracks

Remembering Gilead’s John Martin, whose therapies saved ‘millions’

...our space,” said Stelios Papadopoulos, chairman of Biogen Inc....
BioCentury | Mar 31, 2021
Finance

March 31 Quick Takes: Muted reception for Achilles in market debut; plus BridgeBio-Helsinn, Scribe, Outpace, OnQuality, AffaMed, Treos

...Berkeley professor Jennifer Doudna, the company emerged from stealth in October with a deal with Biogen Inc....
BioCentury | Mar 26, 2021
Product Development

Three’s a crowd in SMA sales: Data Byte

...appreciable Evrysdi sales.Antisense oligo Spinraza nusinersen from Biogen Inc....
BioCentury | Mar 26, 2021
Finance

As valuation swells above $380M, Syncona-backed Gyroscope draws $148M series C, mulls listing

...which went public on NASDAQ in 2017; Biogen Inc....
BioCentury | Mar 22, 2021
Product Development

Genomics plc puts polygenic risk scores to the test with NHS pilot

...$58 million in series A and series B funding, and formed target discovery partnerships with Biogen Inc....
Items per page:
1 - 10 of 5047